Access Bio (Korea) Top Management

950130 Stock  KRW 5,100  10.00  0.20%   
Access Bio employs about 69 people. The company is managed by 7 executives with a total tenure of roughly 161 years, averaging almost 23.0 years of service per executive, having 9.86 employees per reported executive. Analysis of Access Bio's management performance can provide insight into the company performance.
Andrew Gorman  Insider
B Board
Terry Kim  Insider
Chief Africa
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Access Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Access Bio Management Team Effectiveness

The company has return on total asset (ROA) of 0.3467 % which means that it generated a profit of $0.3467 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 108.0209 %, meaning that it generated $108.0209 on every $100 dollars invested by stockholders. Access Bio's management efficiency ratios could be used to measure how well Access Bio manages its routine affairs as well as how well it operates its assets and liabilities.

Access Bio Workforce Comparison

Access Bio is number one stock in number of employees category among its peers. The total workforce of Health Care Equipment & Supplies industry is presently estimated at about 3,279. Access Bio holds roughly 69.0 in number of employees claiming about 2.1% of equities under Health Care Equipment & Supplies industry.
The company has Profit Margin (PM) of 0.4 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.55 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.55.

Access Bio Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Access Bio Price Series Summation is a cross summation of Access Bio price series and its benchmark/peer.

Access Bio Notable Stakeholders

An Access Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Access Bio often face trade-offs trying to please all of them. Access Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Access Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Andrew GormanB BoardProfile
Terry KimChief AfricaProfile
Philip CPATreasurer BoardProfile
John KimManaging PartnerProfile
N MDClinical BoardProfile
YoungHo ChoiCEO PresProfile
Janet StrongDODG BoardProfile

About Access Bio Management Performance

The success or failure of an entity such as Access Bio often depends on how effective the management is. Access Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Access management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Access management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products.
Please note, the presentation of Access Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Access Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Access Bio's management manipulating its earnings.

Access Bio Workforce Analysis

Traditionally, organizations such as Access Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Access Bio within its industry.

Access Bio Manpower Efficiency

Return on Access Bio Manpower

Revenue Per Employee6.4M
Revenue Per Executive63.1M
Net Income Per Employee2.4M
Net Income Per Executive23.7M
Working Capital Per Employee633M
Working Capital Per Executive6.2B

Complementary Tools for Access Stock analysis

When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
CEOs Directory
Screen CEOs from public companies around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators